Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
5 Sep 2023
Global Perspectives in Non-Operative Osteoarthritis (OA) Treatment
The increase in demand for non-operative OA care continues to grow, as healthcare professionals and their patients look for safe…
2 Aug 2023
Link Between Rheumatoid Arthritis and Parkinson’s Disease Found
Patients with rheumatoid arthritis have a 1.74-fold increased risk for developing Parkinson’s disease. Read more…
1 Aug 2023
Risk of Death From All Causes Increased for Patients with Fibromyalgia
Fibromyalgia, which causes fatigue and continual widespread pain across the body, may be linked to an increased risk of death…
5
Mins
13 Jul 2023
EULAR 2023 Abstract Highlights
The following selected highlights spotlight several interesting and timely abstracts presented at the European Alliance of Associations…
6
Mins
13 Jul 2023
European Alliance of Associations for Rheumatology (EULAR) Congress 2023: Take-Home Messages from an Excellent Congress
The congress covered all topics of Rheumatology. During the opening plenary session, Annamaria Iagnocco, European Alliance of Associations…
1
Mins
13 Jul 2023
Prevalence of Risk for Anxiety and Depression in Patients with Rheumatic Diseases
There is a higher prevalence of anxiety and depression in patients with chronic diseases. In a complex relationship, chronic diseases and…
2
Mins
13 Jul 2023
Work Participation and the COVID-19 Pandemic: A Study Within the Amsterdam COVID-19 Cohort Among People with Inflammatory Rheumatic Diseases and Population Controls
Past research has repeatedly shown that patients with inflammatory rheumatic disease (IRD) experience restrictions in work participation.
1
Mins
13 Jul 2023
Predictors of Renal Flares in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a highly heterogenous clinical presentation that can affect…
Loading posts...
« Previous
1
…
37
38
39
40
41
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View